Kenneth L. Kehl

Dana-Farber Cancer Institute — United States

Medicine · Health Sciences

32h-index4.0kcitations241works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(104), Cancer Genomics and Diagnostics(78), Lung Cancer Diagnosis and Treatment(43), Radiomics and Machine Learning in Medical Imaging(36), Lung Cancer Research Studies(27)

Publications238 total

Efficient and Debiased Learning of Average Hazard Under Non-Proportional Hazards
arXiv (Cornell University)·2026Open Access
Efficient and Debiased Learning of Average Hazard Under Non-Proportional Hazards
ArXiv.org·2026Open Access
Emulating Comparative Oncology Trials With Real‐World Evidence Studies ( <scp>ENCORE</scp> ): Process Development and Methodological Considerations for Oncology Real‐World Data
Clinical Pharmacology & Therapeutics·2026
Learning Patient Similarity from Genomics for Precision Oncology
2025Open Access
Cancers modulate p53 truncal neoantigen display to evade T cell detection
2025Open Access
Supplemental Table 1 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
2025Open Access
Supplemental Table 4 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
2025Open Access
Supplemental Table 2 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
2025Open Access
Supplemental Fig. 2 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
2025Open Access
Supplemental Fig. 1 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
2025Open Access
Supplemental Table 3 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
2025Open Access
Supplemental Fig. 3 from The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non–Small Cell Lung Cancer
2025Open Access
ESMO basic requirements for AI-based biomarkers in oncology (EBAI)
Annals of Oncology·2025· 7 citedOpen Access
Biomarker Testing for Non–Small Cell Lung Cancer in Community Practices Operated by an Academic Cancer Center
JCO Oncology Practice·2025
Integrating a Shareable Artificial Intelligence Model Into Clinical Research for Cancer Recurrence in Patients With Breast and Colorectal Cancer
JCO Clinical Cancer Informatics·2025Open Access
P3.14.22 Outcomes to Systemic Standard-Of-Care Therapies in Patients With MTAP-Deleted Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology·2025
Assessing delayed treatment benefits of immunotherapy using long-term average hazard: a novel test/estimation approach
Lifetime Data Analysis·2025Open Access
Opportunities for Causal Machine Learning in Precision Oncology
NEJM AI·2025· 4 cited
Biomarker Testing in Advanced Cancer
JAMA Network Open·2025Open Access
Empirical evaluation of artificial intelligence distillation techniques for ascertaining cancer outcomes from electronic health records
npj Digital Medicine·2025· 1 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Deborah Schrag(23), Michael J. Hassett(12), Eliezer M. Van Allen(12), Jeremy L. Warner(9), Gregory J. Riely(8), Nikolaus Schultz(8), Mark M. Awad(8), Eva M. Lepisto(8), Shawn M. Sweeney(7), Samantha Brown(6), Ethan Cerami(6), Lynette M. Sholl(6), Nancy L. Keating(6), Pasi A. Jänne(6), Jessica A. Lavery(5), Katherine S. Panageas(5), Geoffrey R. Oxnard(5), Bruce E. Johnson(5), Alexander Gusev(5), Jason M. Johnson(5)